Dr. Shea is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1717 6th Ave S
Birmingham, AL 35233Phone+1 800-822-8816Fax+1 205-975-8394
Education & Training
- Washington University in St. Louis School of MedicineClass of 2014
Certifications & Licensure
- AL State Medical License 2016 - 2025
- MO State Medical License 2018 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study) Start of enrollment: 2021 Dec 29
Roles: Contact, Principal Investigator
- Study of Tazemetostat in Lymphoid Malignancies Start of enrollment: 2024 Aug 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 14 citationsEvaluating real-world treatment patterns and outcomes of mantle cell lymphoma.Mayur Narkhede, Gaurav Goyal, Lauren Shea, Amit Mehta, Smith Giri
Blood Advances. 2022-07-26 - 917 citationsCancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoeditingHirokazu Matsushita, Matthew D. Vesely, Daniel C. Koboldt, Charles G. Rickert, Ravindra Uppaluri
Nature. 2012-02-16 - 9 citationsImpact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study.Narendranath Epperla, Rina Li Welkie, Pallawi Torka, Geoffrey Shouse, Reem Karmali
Journal of Hematology & Oncology. 2023-05-08
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: